Combination of Immune Checkpoint Inhibitors with Chemotherapy in Lung Cancer

Tremendous progress has been achieved in the field of immune checkpoint inhibitors (ICIs) therapy in lung cancer in recent years. To generate robust, long-lasting anti-tumor immune responses in lung cancer patients, combinational ICI therapies have been explored deeply. Conventionally, chemotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Wei, Zhang, Lei, Xiu, Zhiming, Guo, Jian, Wang, Liye, Zhou, Yue, Jiao, Yang, Sun, Meiyan, Cai, Jianhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7394580/
https://www.ncbi.nlm.nih.gov/pubmed/32801752
http://dx.doi.org/10.2147/OTT.S255491

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7394580/
https://www.ncbi.nlm.nih.gov/pubmed/32801752
http://dx.doi.org/10.2147/OTT.S255491

Ejemplares similares